Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 39

1.

Clinical characteristics and treatment of inflammatory bowel disease: a comparison of Eastern and Western perspectives.

Park SJ, Kim WH, Cheon JH.

World J Gastroenterol. 2014 Sep 7;20(33):11525-37. doi: 10.3748/wjg.v20.i33.11525.

2.

The effect of cigarette smoking on the clinical course of inflammatory bowel disease.

Karczewski J, Poniedziałek B, Rzymski P, Rychlewska-Hańczewska A, Adamski Z, Wiktorowicz K.

Prz Gastroenterol. 2014;9(3):153-9. doi: 10.5114/pg.2014.43577. Epub 2014 Jun 26.

3.
4.

Prevention and management of nonhealing perineal wounds.

Kamrava A, Mahmoud NN.

Clin Colon Rectal Surg. 2013 Jun;26(2):106-11. doi: 10.1055/s-0033-1348049. Review.

5.

Granulocyte-macrophage colony-stimulating factor autoantibodies: a marker of aggressive Crohn's disease.

Gathungu G, Kim MO, Ferguson JP, Sharma Y, Zhang W, Ng SM, Bonkowski E, Ning K, Simms LA, Croft AR, Stempak JM, Walker N, Huang N, Xiao Y, Silverberg MS, Trapnell B, Cho JH, Radford-Smith GL, Denson LA.

Inflamm Bowel Dis. 2013 Jul;19(8):1671-80. doi: 10.1097/MIB.0b013e318281f506.

6.

Evidence-based clinical practice guidelines for Crohn's disease, integrated with formal consensus of experts in Japan.

Ueno F, Matsui T, Matsumoto T, Matsuoka K, Watanabe M, Hibi T; Guidelines Project Group of the Research Group of Intractable Inflammatory Bowel Disease subsidized by the Ministry of Health, Labour and Welfare of Japan and the Guidelines Committee of the Japanese Society of Gastroenterology.

J Gastroenterol. 2013 Jan;48(1):31-72. doi: 10.1007/s00535-012-0673-1. Epub 2012 Oct 23.

7.

Management of Crohn's disease in smokers: is an alternative approach necessary?

Nos P, Domènech E.

World J Gastroenterol. 2011 Aug 21;17(31):3567-74. doi: 10.3748/wjg.v17.i31.3567. Review.

8.

Familial aggregation in inflammatory bowel disease: is it genes or environment?

Nunes T, Fiorino G, Danese S, Sans M.

World J Gastroenterol. 2011 Jun 14;17(22):2715-22. doi: 10.3748/wjg.v17.i22.2715. Review.

9.

Role of conventional therapies in the era of biological treatment in Crohn's disease.

Gionchetti P, Calabrese C, Tambasco R, Brugnera R, Straforini G, Liguori G, Fornarini GS, Riso D, Campieri M, Rizzello F.

World J Gastroenterol. 2011 Apr 14;17(14):1797-806. doi: 10.3748/wjg.v17.i14.1797. Review.

10.
11.

Current trends in inflammatory bowel disease: the natural history.

Langholz E.

Therap Adv Gastroenterol. 2010 Mar;3(2):77-86. doi: 10.1177/1756283X10361304.

12.

Is the disease course predictable in inflammatory bowel diseases?

Lakatos PL, Kiss LS.

World J Gastroenterol. 2010 Jun 7;16(21):2591-9.

13.

Management of nonhealing perineal wounds.

Genua JC, Vivas DA.

Clin Colon Rectal Surg. 2007 Nov;20(4):322-8. doi: 10.1055/s-2007-991032.

14.

Perianal disease, small bowel disease, smoking, prior steroid or early azathioprine/biological therapy are predictors of disease behavior change in patients with Crohn's disease.

Lakatos PL, Czegledi Z, Szamosi T, Banai J, David G, Zsigmond F, Pandur T, Erdelyi Z, Gemela O, Papp J, Lakatos L.

World J Gastroenterol. 2009 Jul 28;15(28):3504-10.

15.

Does smoking reduce infliximab's effectiveness against Crohn's disease?

Narula N, Fedorak RN.

Can J Gastroenterol. 2009 Feb;23(2):121-5. Review.

16.

Postoperative Crohn's disease recurrence: a practical approach.

Nos P, Domenech E.

World J Gastroenterol. 2008 Sep 28;14(36):5540-8. Review.

17.

Nicotine enemas for active Crohn's colitis: an open pilot study.

Ingram JR, Rhodes J, Evans BK, Thomas GA.

Gastroenterol Res Pract. 2008;2008:237185. doi: 10.1155/2008/237185.

18.

Risk factors for surgical recurrence after ileocolic resection of Crohn's disease.

Unkart JT, Anderson L, Li E, Miller C, Yan Y, Gu CC, Chen J, Stone CD, Hunt S, Dietz DW.

Dis Colon Rectum. 2008 Aug;51(8):1211-6. doi: 10.1007/s10350-008-9348-7. Epub 2008 Jun 7.

19.

Inflammatory bowel disease: genetic and epidemiologic considerations.

Cho JH.

World J Gastroenterol. 2008 Jan 21;14(3):338-47. Review.

20.

Innate immunity in inflammatory bowel disease: a disease hypothesis.

Marks DJ, Segal AW.

J Pathol. 2008 Jan;214(2):260-6. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk